MarketCap
Facebook
X
TelegramGeschäftsbericht 2022
hinzugefügt 23.12.2023
HEXO Corp. Finanzkreislauf 2011-2026 | HEXO
Finanzkreislauf Jährlich HEXO Corp.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 775 | 451 | - | - | - | - | - |
Alle Zahlen in CAD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 775 | 451 | 613 |
Finanzkreislauf anderer Aktien in der Arzneimittelhersteller
| Name | Finanzkreislauf | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
AcelRx Pharmaceuticals
ACRX
|
-38 | - | 7.5 % | $ 6.35 M |  USA |
 |
Alimera Sciences
ALIM
|
-128 | - | - | $ 142 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
460 | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
-206 | - | 10.11 % | $ 58.2 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
-224 | - | 0.86 % | $ 117 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
139 | - | -39.89 % | $ 27.7 M | USA |
 |
Aurora Cannabis
ACB
|
1.45 K | $ 3.43 | 3.31 % | $ 86.3 M |  Canada |
 |
Catalent
CTLT
|
110 | - | - | $ 11.5 B | USA |
 |
Athenex
ATNX
|
137 | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
192 | - | - | $ 2.06 B |  France |
 |
Pacira BioSciences
PCRX
|
209 | $ 23.16 | -0.19 % | $ 1.07 B | USA |
 |
Cronos Group
CRON
|
213 | $ 2.64 | 2.13 % | $ 1.34 B | Canada |
 |
DURECT Corporation
DRRX
|
41.4 | - | - | $ 50.1 M | USA |
 |
Emergent BioSolutions
EBS
|
181 | $ 8.36 | 4.3 % | $ 428 M | USA |
 |
Endo International plc
ENDP
|
141 | - | - | $ 28.9 M |  Irlanda |
 |
Perrigo Company plc
PRGO
|
137 | $ 9.84 | 2.07 % | $ 1.36 B | USA |
 |
Evoke Pharma
EVOK
|
45.7 | - | - | $ 36.6 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
-161 | $ 3.03 | -3.19 % | $ 42.6 M | USA |
 |
Rockwell Medical
RMTI
|
45 | $ 1.08 | 4.37 % | $ 25.2 M | USA |
 |
Bausch Health Companies
BHC
|
78.9 | $ 5.2 | 4.0 % | $ 1.9 B | Canada |
 |
PetIQ
PETQ
|
53.8 | - | 1.64 % | $ 400 M | USA |
 |
OptiNose
OPTN
|
314 | - | - | $ 1.08 B | USA |
 |
PLx Pharma
PLXP
|
111 | - | -27.8 % | $ 2.56 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
150 | $ 2.34 | - | $ 2.9 M | USA |
 |
ProPhase Labs
PRPH
|
96 | - | - | $ 5.07 M | USA |
 |
Evolus
EOLS
|
74.8 | $ 4.44 | 0.23 % | $ 286 M | USA |
 |
Radius Health
RDUS
|
-53.5 | - | - | $ 1.42 B | USA |
 |
Tilray
TLRY
|
169 | $ 7.02 | 5.45 % | $ 4.34 B | Canada |
 |
OrganiGram Holdings
OGI
|
2.92 K | $ 1.39 | 3.84 % | $ 402 M | Canada |
 |
SCYNEXIS
SCYX
|
106 | $ 0.92 | 2.51 % | $ 45.9 M | USA |
 |
Jupiter Wellness
JUPW
|
-21.1 | - | - | $ 33.6 M | USA |
 |
China Pharma Holdings
CPHI
|
164 | $ 0.59 | 3.79 % | $ 10.3 M |  China |
 |
Veru
VERU
|
6.7 | $ 2.3 | 0.44 % | $ 310 M | USA |
 |
Lannett Company
LCI
|
173 | - | 1.15 % | $ 7.11 M | USA |
 |
Harrow Health
HROW
|
18.3 | $ 36.09 | 2.53 % | $ 1.33 B | USA |
 |
Viatris
VTRS
|
155 | $ 13.59 | 1.72 % | $ 16.3 B | USA |
 |
Organogenesis Holdings
ORGO
|
64.5 | $ 2.49 | 3.31 % | $ 328 M | USA |
 |
Canopy Growth Corporation
CGC
|
177 | $ 1.0 | 4.19 % | $ 108 M | Canada |
 |
cbdMD
YCBD
|
92 | $ 0.79 | 2.82 % | $ 3.41 M | USA |
 |
Assertio Holdings
ASRT
|
467 | $ 16.81 | 1.82 % | $ 108 M | USA |
 |
TherapeuticsMD
TXMD
|
-723 | $ 2.28 | -0.44 % | $ 23.8 M | USA |
 |
Recro Pharma
REPH
|
105 | - | -4.76 % | $ 65.3 M | USA |